The 13th China Beijing International Technological Industry Exposition was uncurtained at Beijing International Exposition Center with great concerns on May 27. Beijing Haiyan Pharmaceutical Company affiliated to YRPG appeared in the expo with its new product Manidipine Hydrochloride developed by the Company independently.
With the theme of "intensifying the independent innovation and accelerating the transformation of development methods", the expo was focusing on exhibiting the latest scientific and technological achievements of new drug, new energy, energy conservation and environmental protection, electric vehicles, new materials, information industry and biology breeding. Over 70 governments, economic and trade delegations from 11 international organizations and 20 countries and regions attended the expo while large delegations of governments and enterprises from 30 domestic provinces, cities, Hongkong, Macao and Taiwan were engaged therein to exhibit their advantageous industries, important industry cooperation projects and open environment. It was the largest expo of its kind ever since. Tens of high-tech technological exhibitions, forums, project promotion conferences, economic and trade fairs were carried out within a week.
As one of the "G20 Potential Enterprises" in Beijing bio-pharmaceutical industry, Beijing Haiyan Pharmaceutical Company affiliated to YRPG cut a figure in the expo by presenting its new high-tech product---the new chemical drug Manidipine Hydrochloride whose unique curative effect and wide market prospect were widely concerned by people from all circles. The future development of Beijing Haiyan Pharmaceutical Company would greatly depend on the sound environment created by the city for the technological innovation and industrialization; thus it would strive to develop high-tech pharmaceutical industry and realize the enterprise’s development in a leaping-forward manner.